India Says WHO Drops Redefinition Of Generics As Counterfeit
This article was originally published in PharmAsia News
Executive Summary
Indian pharmaceuticals were cheered by a decision of the World Health Organization not to take the route of the European Union and consider generic drugs as counterfeit. The WHO had considered such a move, but India and Brazil launched major campaigns against it and the UN organization decided it would not do so in a determination that has not been made official. The WHO killed a resolution that would have adopted the definition at a recent meeting. India and Brazil, members of the group, argued the WHO's role was in public health, not intellectual property rights. (Click here for more